Financial Information
- İntema
- Eczacıbaşı Pharmaceutical and Industrial Investment Co.
- Financial Information
- Announcements and Presentations
- Corporate Governance
- General Assembly
- Investor's Calendar
- Contact Us
- Eczacıbaşı Investment Holding Co.
- Financial Information
- Announcements and Presentations
- Corporate Governance
- General Assembly
- Investor's Calendar
- Contact Us
- Eczacıbaşı Group Annual Report
Financial Highlights
| SUMMARIZED FINANCIAL DATA (Thousand TL) | 2019/09 | 2018/09 |
| Revenue | 610,711 | 510,386 |
| Gross Profit | 215,334 | 178,794 |
| Operating Profit | 146,370 | 256,496 |
| Depreciation and Amortisation | 16,099 | 7,844 |
| EBITDA | 162,469 | 264,340 |
| Net Income | 102,390 | 291,052 |
| 2019/09 | 2018/12 | |
| Total Assets | 4,416,028 | 4,456,472 |
| Total Shareholder's Equity | 3,895,953 | 3,997,844 |
| Total Current Assets | 905,183 | 912,383 |
| Total Current Liabilities | 342,301 | 241,737 |
| Capital Expenditures | 30,334 | 16,945 |
| Liquidity Ratios | 2019/09 | 2018/09 |
| - Current Ratio | 2.64 | 3.88 |
| - Liquidity Ratio | 2.38 | 3.60 |
| The Ratios Related to Financial Structure | 2019/09 | 2018/09 |
| - Total Liabilities / Total Assets | 0.12 | 0.11 |
| - Total Shareholders' Equity / Total Assets | 0.88 | 0.89 |
| - Total Shareholders' Equity / Total Liabilities | 7.49 | 7.89 |
| Profitability Ratios | 2019/09 | 2018/09 |
| - Net Income / Total Shareholders' Equity | 0.03 | 0.08 |
| - Net Income / Total Assets | 0.02 | 0.07 |
| - Net Income / Revenue | 0.17 | 0.57 |